Bariatric endoscopy: current state of the art, emerging technologies, and challenges

References

• Obesity: preventing and managing the global epidemic. Report of a WHO consultation. WHO Tech Rep Ser. 2000;894:1–253.
   Google Scholar
• Wilson PW, Kannel WB, Silbershatz H, et al. Clustering of metabolic factors and coronary heart disease. Arch Intern Med. 1999;159:1104–1109.
   PubMed Web of Science ®Google Scholar
• Frühbeck G, Toplak H, Woodward E, et al. Executive Committee of the European Association for the study of obesity. Obesity: the gateway to ill health - an EASO position statement on a rising public health, clinical and scientific challenge in Europe. Obes Facts. 2013;6:117–120.
   PubMed Web of Science ®Google Scholar
• Hankey CR. Management of obesity: weight-loss interventions in the treatment of obesity. Proc Nutr Soc. 2010;69:34–38.
   PubMed Web of Science ®Google Scholar
• Manning S, Pucci A, Finer N. Pharmacotherapy for obesity: novel agents and paradigms. Ther Adv Chronic Dis. 2014;5:135–148.
   PubMedGoogle Scholar
• Robinson MK. Surgical treatment of obesity—weighing the facts. N Engl J Med. 2009;361:520–521.
   PubMed Web of Science ®Google Scholar
• Morino M, Toppino M, Forestieri P, et al. Mortality after bariatric surgery: analysis of 13,871 morbidly obese patients from a national registry. Ann Surg. 2007;246:1002–1007.
   PubMed Web of Science ®Google Scholar
• Buchwald H, Estok R, Fahrbach K, et al. Trends in mortality in bariatric surgery: a systematic review and meta-analysis. Surgery. 2007;142:621–632.
   PubMed Web of Science ®Google Scholar
• Thompson CC. Endoscopic therapy of obesity: a new paradigm in bariatric care. Gastrointest Endosc. 2010;72:505–507.
   PubMed Web of Science ®Google Scholar
• Van Rijn S, Roebroek YG, Masclee AA, et al. structural endoscopic techniques to treat obesity: a review. Surg Technol Int. 2015;26:84–91.
   PubMedGoogle Scholar
• Dumonceau JM. Evidence-based review of the bioenterics intragastric balloon for weight loss. Obes Surg. 2008;18(12):1611–1617.
   PubMed Web of Science ®Google Scholar
• Van Hee R, Van Wiemeersch B, Lasters B, et al. Use of anti-emetics after intragastric balloon placement: experience with three different drug treatments. Obes Surg. 2003;13:932–937.
   PubMed Web of Science ®Google Scholar
• Genco A, Bruni T, Doldi SB, et al. BioEnterics intragastric balloon: the italian experience with 2515 patients. Obes Surg. 2005;15:1161–1164.
   PubMed Web of Science ®Google Scholar
• Lopez-Nava G, Rubio MA, Prados S, et al. BioEnterics intragastric balloon (BIB). Single ambulatory center Spanish experience with 714 consecutive patients treated with one or two consecutive balloons. Obes Surg. 2011;21:5–9.
   PubMed Web of Science ®Google Scholar
• Stimac D, Majanovic SK, Turk T, et al. Intragastric balloon treatment for obesity: results of a large single center prospective study. Obes Surg. 2011;21:551–555.
   PubMed Web of Science ®Google Scholar
• Gaur S, Levy S, Mathus-Vliegen L, et al. Balancing risk and reward: a critical review of the intragastric balloon for weight loss. Gastrointest Endosc. 2015;81(6):1330–1336.
   PubMed Web of Science ®Google Scholar
• Dastis NS, François E, Deviere J, et al. Intragastric balloon for weight loss: results in 100 individuals followed for at least 2.5 years. Endoscopy. 2009;41:575–580.
   PubMed Web of Science ®Google Scholar
• Carvalho GL, Barros CB, Moraes CE, et al. The use of an improved intragastric balloon technique to reduce weight in pre-obese patients - preliminary results. Obes Surg. 2011;21:924–927.
   PubMed Web of Science ®Google Scholar
• Bužga M, Evžen M, Pavel K, et al. Effects of the intragastric balloon MedSil® on weight loss, fat tissue, lipid metabolism, and hormones involved in energy balance. Obes Surg. 2014;24:909–915.
   PubMed Web of Science ®Google Scholar
• Brooks J, Srivastava ED, Mathus-Vliegen EM. One-year adjustable intragastric balloons: results in 73 consecutive patients in the U.K. Obes Surg. 2014;24:813–819.
   PubMed Web of Science ®Google Scholar
• Genco A, Dellepiane D, Baglio G, et al. Adjustable intragastric balloon vs non-adjustable intragastric balloon: case-control study on complications, tolerance, and efficacy. Obes Surg. 2013;23:953–958.
   PubMed Web of Science ®Google Scholar
• Ponce J, Woodman G, Swain J, et al. REDUCE Pivotal Trial Investigators. The REDUCE pivotal trial: a prospective, randomized controlled pivotal trial of a dual intragastric balloon for the treatment of obesity. Surg Obes Relat Dis. 2015;11:874–881.
   PubMed Web of Science ®Google Scholar
• De Castro ML, Morales MJ, Del Campo V, et al. Efficacy, safety, and tolerance of two types of intragastric balloons placed in obese subjects: a double-blind comparative study. Obes Surg. 2010;20:1642–1646.
   PubMed Web of Science ®Google Scholar
• Trande P, Mussetto A, Mirante VG, et al. Efficacy, tolerance and safety of new intragastric air-filled balloon (Heliosphere BAG) for obesity: the experience of 17 cases. Obes Surg. 2010;20:1227–1230.
   PubMed Web of Science ®Google Scholar
• Mion F, Ibrahim M, Marjoux S, et al. Swallowable Obalon® gastric balloons as an aid for weight loss: a pilot feasibility study. Obes Surg. 2013;23:730–733.
   PubMed Web of Science ®Google Scholar
• Martin CK, Bellanger DE, Rau KK, et al. Safety of the Ullorex oral intragastric balloon for the treatment of obesity. J Diabetes Sci Technol. 2007;1:574–581.
   PubMedGoogle Scholar
• Lopasso FP, Sakai P, Gazi BM, et al. A pilot study to evaluate the safety, tolerance, and efficacy of a novel stationary antral balloon (SAB) for obesity. J Clin Gastroenterol. 2008;42:48–53.
   PubMed Web of Science ®Google Scholar
• Marinos G, Eliades C, Raman Muthusamy V, et al. Weight loss and improved quality of life with a nonsurgical endoscopic treatment for obesity: clinical results from a 3- and 6-month study. Surg Obes Relat Dis. 2014;10:929–934.
   PubMed Web of Science ®Google Scholar
• Sauer N, Rösch T, Pezold J, et al. A new endoscopically implantable device (SatiSphere) for treatment of obesity-efficacy, safety, and metabolic effects on glucose, insulin, and GLP-1 levels. Obes Surg. 2013;23:1727–1733.
   PubMed Web of Science ®Google Scholar
• Kadirkamanathan SS, Evans DF, Gong F, et al. Antireflux operations at flexible endoscopy using endoluminal stitching techniques: an experimental study. Gastrointest Endosc. 1996;44:133–143.
   PubMed Web of Science ®Google Scholar
• Rothstein RI, Filipi CJ. Endoscopic suturing for gastroesophageal reflux disease: clinical outcome with the Bard EndoCinch. Gastrointest Endosc Clin N Am. 2003;13:89–101.
   PubMedGoogle Scholar
• Schwartz MP, Wellink H, Gooszen HG, et al. Endoscopic gastroplication for the treatment of gastro-oesophageal reflux disease: a randomised, sham-controlled trial. Gut. 2007;56:20–28.
   PubMed Web of Science ®Google Scholar
• Fogel R, De Fogel J, Bonilla Y, et al. Clinical experience of transoral suturing for an endoluminal vertical gastroplasty: 1-year follow-up in 64 patients. Gastrointest Endosc. 2008;68:51–58.
   PubMed Web of Science ®Google Scholar
• Brethauer SA, Chand B, Schauer PR, et al. Transoral gastric volume reduction for weight management: technique and feasibility in 18 patients. Surg Obes Relat Dis. 2010;6:689–694.
   PubMed Web of Science ®Google Scholar
• Kumar N. Endoscopic therapy for weight loss: gastroplasty, duodenal sleeves, intragastric balloons, and aspiration. World J Gastrointest Endosc. 2015;7(9):847–859.
   PubMed Web of Science ®Google Scholar
• Abu Dayyeh BK, Rajan E, Gostout CJ. Endoscopic sleeve gastroplasty: a potential endoscopic alternative to surgical sleeve gastrectomy for treatment of obesity. Gastrointest Endosc. 2013;78:530–535.
   PubMed Web of Science ®Google Scholar
• Sharaiha RZ, Kedia P, Kumta N, et al. Initial experience with endoscopic sleeve gastroplasty: technical success and reproducibility in the bariatric population. Endoscopy. 2015;47:164–166.
   PubMed Web of Science ®Google Scholar
• Lopez-Nava G, Galv˜ao M, Da Bautista-Casta˜no I, et al. Endoscopic sleeve gastroplasty with 1-year follow-up: factors predictive of success. Endosc Int Open. 2016;4(2):E222–7.
   PubMed Web of Science ®Google Scholar
• Devière J, Ojeda Valdes G, Cuevas Herrera L, et al. Safety, feasibility and weight loss after transoral gastroplasty: first human multicenter study. Surg Endosc. 2008;22:589–598.
   PubMed Web of Science ®Google Scholar
• Moreno C, Closset J, Dugardeyn S, et al. Transoral gastroplasty is safe, feasible and induces significant weight loss in morbidly obese patients: results of the second human pilot study. Endoscopy. 2008;40:406–413.
   PubMed Web of Science ®Google Scholar
• Familiari P, Costamagna G, Bléro D, et al. Transoral gastroplasty for morbid obesity: a multicenter trial with a 1-year outcome. Gastrointest Endosc. 2011;74:1248–1258.
   PubMed Web of Science ®Google Scholar
• Biertho L, Hould F-S, Lebel S, et al. Transoral endoscopic restrictive implant system: a new endoscopic technique for the treatment of obesity. Surg Obes Relat Dis. 2010;6:203–205.
   PubMed Web of Science ®Google Scholar
• Legner A, Altorjay A, Juhasz A, et al. Transoral mucosal excision sutured gastroplasty: a pilot study for GERD and obesity with two-year follow-up. Surg Innov. 2014;21:456–463.
   PubMed Web of Science ®Google Scholar
• Verlaan T, De Jong K, De La Mar-Ploem ED, et al. Trans-oral endoscopic restrictive implant system: endoscopic treatment of obesity? Surg Obes And Relat Dis. 2016; 12(9):1711–1718.
   PubMed Web of Science ®Google Scholar
• López-Nava G, Bautista-Castaño I, Jimenez A, et al. The primary obesity surgery endolumenal (POSE) procedure: one-year patient weight loss and safety outcomes. Surg Obes Relat Dis. 2015;11:861–865.
   PubMed Web of Science ®Google Scholar
• Ellsmere JC, Thompson CC, Brugge WR, et al. Endoscopic interventions for weight loss surgery. Obesity. 2009;17:929–933.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Grunert L, Galvao Neto MP, Alamo M, et al. First human experience with endoscopically delivered and retrieved duodenal-jejunal bypass sleeve. Surg Obes Relat Dis. 2008;4:55–59.
   PubMed Web of Science ®Google Scholar
• Tarnoff M, Rodriguez L, Escalona A, et al. Open label, prospective, randomized controlled trial of an endoscopic duodenal-jejunal bypass sleeve versus low calorie diet for pre-operative weight loss in bariatric suregry. Surg Endosc. 2009;23:650–656.
   PubMed Web of Science ®Google Scholar
• Schouten R, Rijs CS, Bouvy ND, et al. A multicenter, randomized efficacy study of the EndoBarrier Gastrointestinal Liner for presurgical weight loss prior to bariatric surgery. Ann Surg. 2010;251:236–243.
   PubMed Web of Science ®Google Scholar
• Gersin KS, Rothstein RI, Rosenthal J, et al. Open-label, sham-controlled trial of an endoscopic duodenojejunal bypass liner for preoperative weight loss in bariatric surgery candidates. Gastrointest Endosc. 2010;71:976–982.
   PubMed Web of Science ®Google Scholar
• De Moura EG, Martins BC, Lopes GS, et al. Metabolic improvements in obese type 2 diabetes subjects implanted for 1 year with an endoscopically deployed duodenal-jejunal bypass liner. Diabetes Technol Ther. 2012;14:183–189.
   PubMed Web of Science ®Google Scholar
• Koehestanie P, De Jonge C, Berends FJ, et al. The effect of the endoscopic duodenal-jejunal bypass liner on obesity and type 2 diabetes mellitus, a multicenter randomized controlled trial. Ann Surg. 2014;260:984–992.
   PubMed Web of Science ®Google Scholar
• Rohde U, Hedbäck N, Gluud L, et al. Effect of the EndoBarrier Gastrointestinal Liner on obesity and type 2 diabetes: a systematic review and meta-analysis. Diabetes, Obesity Metabolism. 2016;18:300–305.
   PubMed Web of Science ®Google Scholar
• Sandler BJ, Rumbaut R, Swain CP, et al. Human experience with an endoluminal, endoscopic, gastrojejunal bypass sleeve. Surg Endosc. 2011;25:3028–3033.
   PubMed Web of Science ®Google Scholar
• Sandler BJ, Rumbaut R, Swain CP, et al. One-year human experience with a novel endoluminal, endoscopic gastric bypass sleeve for morbid obesity. Surg Endosc. 2015;29:3298–3303.
   PubMed Web of Science ®Google Scholar
• Peeters TL. Potential of ghrelin as a therapeutic approach for gastrointestinal motility disorders. Curr Opin Pharmacol. 2006;6:553–558.
   PubMed Web of Science ®Google Scholar
• Mittermair R, Keller C, Geibel J. Intragastric injection of botulinum toxin A for the treatment of obesity. Obes Surg. 2007;17:732–736.
   PubMed Web of Science ®Google Scholar
• Foschi D, Corsi F, Iazzaroni M, et al. Treatment of morbid obesity by intraparietogastric administration of botulinum toxin: a randomized, double-blind controlled study. Int J Obes (Lond). 2007;31:707–712.
   PubMed Web of Science ®Google Scholar
• Li L, Liu QS, Liu WH, et al. Treatment of obesity by endoscopic gastric intramural injection of botulinum toxin A: a randomized clinical trial. Hepato-Gastroenterology. 2012;59(118):2003–2007.
   PubMed Web of Science ®Google Scholar
• Bang CS, Baik GH, Shin IS, et al. Effect of intragastric injection of botulinum toxin A for the treatment of obesity: a meta-analysis and meta-regression. Gastrointest Endosc. 2015;81:1141–1149.
   PubMed Web of Science ®Google Scholar
• Sarr MG, Billington CJ, Brancatisano R, et al. EMPOWER Study Group. The EMPOWER study: randomized, prospective, double-blind, multicenter trial of vagal blockade to induce weight loss in morbid obesity. Obes Surg. 2012;22:1771–1782.
   PubMed Web of Science ®Google Scholar
• Ikramuddin S, Blackstone RP, Brancatisano A, et al. Effect of reversible intermittent intra-abdominal vagal nerve blockade on morbid obesity: the recharge randomized clinical trial. JAMA. 2014;312:915–922.
   PubMed Web of Science ®Google Scholar
• Xu X, Pasricha PJ, Chen JD. Feasibility of gastric electrical stimulation by use of endoscopically placed electrodes. Gastrointest Endosc. 2007;66:981–986.
   PubMed Web of Science ®Google Scholar
• Sallam HS, Chen JD, Pasricha PJ. Feasibility of gastric electrical stimulation by percutaneous endoscopic transgastric electrodes. Gastrointest Endosc. 2008;68:754–759.
   PubMed Web of Science ®Google Scholar
• Sanmiguel CP, Conklin JL, Cunneen SA, et al. Gastric electrical stimulation with the TANTALUS system in obese type 2 diabetes patients: effect on weight and gylcemic control. J Diabetes Sci Technol. 2009;3:964–970.
   PubMedGoogle Scholar
• Zhang Y, Du S, Fang L, et al. Retrograde gastric electrical stimulation suppresses calorie intake in obese subjects. Obesity. 2014;22(6):1447–1451.
   PubMed Web of Science ®Google Scholar
• Sullivan S, Stein R, Jonnalagadda S, et al. Aspiration therapy leads to weight loss in obese subjects: a pilot study. Gastroenterology. 2013;145:1245–1252.
   PubMed Web of Science ®Google Scholar
• Forssell H, Norén E. A novel endoscopic weight loss therapy using gastric aspiration: results after 6 months. Endoscopy. 2015;47:68–71.
   PubMed Web of Science ®Google Scholar